Actively Recruiting
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
Led by University Hospital Bispebjerg and Frederiksberg · Updated on 2026-03-20
200
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.
CONDITIONS
Official Title
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Bipolar Disorder, type II confirmed by SCAN interview
- Age between 18 and 70 years
- Able to give informed consent
You will not qualify if you...
- Past non-response or intolerance to lamotrigine or lithium after more than 6 weeks of proper treatment
- Currently taking mood stabilizers at enrollment
- Severe chronic kidney disease
- Severe cardiac insufficiency
- Brugada syndrome
- Severe hypothyroidism not controlled by treatment
- Women who are pregnant, breastfeeding, or planning pregnancy soon
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Psychiatric Center Copenhagen
Copenhagen, Denmark
Actively Recruiting
Research Team
L
Lars Vedel Kessing, professor, MD, DMSc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here